Russell Investments Group, Ltd. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 57 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2017. The put-call ratio across all filers is 1.80 and the average weighting 0.7%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2020$17,000
-96.9%
14,100
-95.4%
0.00%
-100.0%
Q3 2020$551,000
-78.8%
306,343
-1.5%
0.00%
-83.3%
Q2 2020$2,605,000
+95.7%
310,930
+22.4%
0.01%
+100.0%
Q1 2020$1,331,000
+12.0%
254,110
+16.6%
0.00%
+50.0%
Q4 2019$1,188,000
+11.9%
217,9590.0%0.00%0.0%
Q3 2019$1,062,000
+24.4%
217,959
+119.4%
0.00%0.0%
Q4 2016$854,00099,3590.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders